Cargando…
Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc
BACKGROUND: Long non-coding RNAs (lncRNAs) have been considered as one type of gene expression regulator for cancer development, but it is not clear how these are regulated. This study aimed to identify a specific lncRNA that promotes glioma progression. METHODS: RNA sequencing (RNA-seq) and quantit...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543865/ https://www.ncbi.nlm.nih.gov/pubmed/34696771 http://dx.doi.org/10.1186/s13046-021-02129-9 |
_version_ | 1784589700752736256 |
---|---|
author | Bian, Erbao Chen, Xueran Cheng, Li Cheng, Meng Chen, Zhigang Yue, Xiaoyu Zhang, Zhengwei Chen, Jie Sun, Libo Huang, Kebing Huang, Cheng Fang, Zhiyou Zhao, Bing Li, Jun |
author_facet | Bian, Erbao Chen, Xueran Cheng, Li Cheng, Meng Chen, Zhigang Yue, Xiaoyu Zhang, Zhengwei Chen, Jie Sun, Libo Huang, Kebing Huang, Cheng Fang, Zhiyou Zhao, Bing Li, Jun |
author_sort | Bian, Erbao |
collection | PubMed |
description | BACKGROUND: Long non-coding RNAs (lncRNAs) have been considered as one type of gene expression regulator for cancer development, but it is not clear how these are regulated. This study aimed to identify a specific lncRNA that promotes glioma progression. METHODS: RNA sequencing (RNA-seq) and quantitative real-time PCR were performed to screen differentially expressed genes. CCK-8, transwell migration, invasion assays, and a mouse xenograft model were performed to determine the functions of TMEM44-AS1. Co-IP, ChIP, Dual-luciferase reporter assays, RNA pulldown, and RNA immunoprecipitation assays were performed to study the molecular mechanism of TMEM44-AS1 and the downstream target. RESULTS: We identified a novel lncRNA TMEM44-AS1, which was aberrantly expressed in glioma tissues, and that increased TMEM44-AS1 expression was correlated with malignant progression and poor survival for patients with glioma. Expression of TMEM44-AS1 increased the proliferation, colony formation, migration, and invasion of glioma cells. Knockdown of TMEM44-AS1 in glioma cells reduced cell proliferation, colony formation, migration and invasion, and tumor growth in a nude mouse xenograft model. Mechanistically, TMEM44-AS1 is directly bound to the SerpinB3, and sequentially activated Myc and EGR1/IL-6 signaling; Myc transcriptionally induced TMEM44-AS1 and directly bound to the promoter and super-enhancer of TMEM44-AS1, thus forming a positive feedback loop with TMEM44-AS. Further studies demonstrated that Myc interacts with MED1 regulates the super-enhancer of TMEM44-AS1. More importantly, a novel small-molecule Myc inhibitor, Myci975, alleviated TMEM44-AS1-promoted the growth of glioma cells. CONCLUSIONS: Our study implicates a crucial role of the TMEM44-AS1-Myc axis in glioma progression and provides a possible anti-glioma therapeutic agent. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02129-9. |
format | Online Article Text |
id | pubmed-8543865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85438652021-10-25 Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc Bian, Erbao Chen, Xueran Cheng, Li Cheng, Meng Chen, Zhigang Yue, Xiaoyu Zhang, Zhengwei Chen, Jie Sun, Libo Huang, Kebing Huang, Cheng Fang, Zhiyou Zhao, Bing Li, Jun J Exp Clin Cancer Res Research BACKGROUND: Long non-coding RNAs (lncRNAs) have been considered as one type of gene expression regulator for cancer development, but it is not clear how these are regulated. This study aimed to identify a specific lncRNA that promotes glioma progression. METHODS: RNA sequencing (RNA-seq) and quantitative real-time PCR were performed to screen differentially expressed genes. CCK-8, transwell migration, invasion assays, and a mouse xenograft model were performed to determine the functions of TMEM44-AS1. Co-IP, ChIP, Dual-luciferase reporter assays, RNA pulldown, and RNA immunoprecipitation assays were performed to study the molecular mechanism of TMEM44-AS1 and the downstream target. RESULTS: We identified a novel lncRNA TMEM44-AS1, which was aberrantly expressed in glioma tissues, and that increased TMEM44-AS1 expression was correlated with malignant progression and poor survival for patients with glioma. Expression of TMEM44-AS1 increased the proliferation, colony formation, migration, and invasion of glioma cells. Knockdown of TMEM44-AS1 in glioma cells reduced cell proliferation, colony formation, migration and invasion, and tumor growth in a nude mouse xenograft model. Mechanistically, TMEM44-AS1 is directly bound to the SerpinB3, and sequentially activated Myc and EGR1/IL-6 signaling; Myc transcriptionally induced TMEM44-AS1 and directly bound to the promoter and super-enhancer of TMEM44-AS1, thus forming a positive feedback loop with TMEM44-AS. Further studies demonstrated that Myc interacts with MED1 regulates the super-enhancer of TMEM44-AS1. More importantly, a novel small-molecule Myc inhibitor, Myci975, alleviated TMEM44-AS1-promoted the growth of glioma cells. CONCLUSIONS: Our study implicates a crucial role of the TMEM44-AS1-Myc axis in glioma progression and provides a possible anti-glioma therapeutic agent. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02129-9. BioMed Central 2021-10-25 /pmc/articles/PMC8543865/ /pubmed/34696771 http://dx.doi.org/10.1186/s13046-021-02129-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Bian, Erbao Chen, Xueran Cheng, Li Cheng, Meng Chen, Zhigang Yue, Xiaoyu Zhang, Zhengwei Chen, Jie Sun, Libo Huang, Kebing Huang, Cheng Fang, Zhiyou Zhao, Bing Li, Jun Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc |
title | Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc |
title_full | Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc |
title_fullStr | Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc |
title_full_unstemmed | Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc |
title_short | Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc |
title_sort | super-enhancer-associated tmem44-as1 aggravated glioma progression by forming a positive feedback loop with myc |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543865/ https://www.ncbi.nlm.nih.gov/pubmed/34696771 http://dx.doi.org/10.1186/s13046-021-02129-9 |
work_keys_str_mv | AT bianerbao superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT chenxueran superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT chengli superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT chengmeng superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT chenzhigang superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT yuexiaoyu superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT zhangzhengwei superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT chenjie superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT sunlibo superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT huangkebing superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT huangcheng superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT fangzhiyou superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT zhaobing superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc AT lijun superenhancerassociatedtmem44as1aggravatedgliomaprogressionbyformingapositivefeedbackloopwithmyc |